Kenji Mashimo
Wakayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.
Journal: Journal of cellular physiology
Published: April 15, 2017
Statins inhibited the MIP-1α expression via inhibition of Ras/ERK and Ras/Akt pathways in myeloma cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 08, 2015
Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model.
Journal: American journal of cancer research
Published: September 02, 2015
Bisphosphonates and statins inhibit expression and secretion of MIP-1α via suppression of Ras/MEK/ERK/AML-1A and Ras/PI3K/Akt/AML-1A pathways.
Journal: American journal of cancer research
Published: October 16, 2014
Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation.
Journal: Journal of biomedical science
Published: September 18, 2013
Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 22, 2013
By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
Journal: Leukemia research
Published: June 25, 2013
Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugs.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 29, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026